Biological DMARDs
Abbildung 1: Nell-Duxneuner V, et al. Drug survival of all drugs in comparison.


Keywords: Biologika,  DMARD,  Mineralstoffwechsel,  Rheumatoide Arthritis

Chondrozyten
Abbildung 2: Moazedi-Fürst FC, et al. 2A3 (4 different concentrations) treatment results in a decrease of cluster rate and cluster size.


Keywords: Chondrozyten,  Diagramm,  LAMA4,  Mineralstoffwechsel,  Osteoarthritis

Chondrozyten
Abbildung 3: Moazedi-Fürst FC, et al. F-Actin staining of human chondrocytes: (A) untreated, (B) IgM-treated, and (C) treated with 2A3: little hairbrush disappeared, surface seems even.


Keywords: Chondrozyten,  LAMA4,  Mineralstoffwechsel,  Osteoarthritis

Lupus erythematosus
Abbildung 4: Schwarzecker B, et al. Progression of paw swelling and loss of grip strength.


Keywords: Arthritis,  Diagramm,  Gelenk,  Lupus erythematodes,  Mineralstoffwechsel

Lupus erythematodes
Abbildung 5: Schwarzecker B, et al. Clinical signs of arthritis and Arthritis Severity Score.


Keywords: Arthritis,  Diagramm,  Gelenk,  Klinik,  Lupus erythematodes,  Mineralstoffwechsel

Lupus erythematodes
Abbildung 6: Schwarzecker B, et al. Histological parameters of arthritis.


Keywords: Arthritis,  Diagramm,  Gelenk,  Histologie,  Lupus erythematodes,  Mineralstoffwechsel

Systemische Sklerose
Abbildung 7: Kielhauser SM, et al. Staining of LAMA4 in the endothelial cells of SKL6 before and after rituximab therapy.


Keywords: Histologie,  LAMA4,  Mineralstoffwechsel,  Rituximab,  systemische Sklerose,  Therapie

Systemische Sklerose
Abbildung 8: Kielhauser SM, et al. CD3+ lymphocytes in scleroderma skin before and after rituximab therapy.


Keywords: Histologie,  Lymphozyten,  Mineralstoffwechsel,  Rituximab,  systemische Sklerose,  Therapie

Lupus erythematodes
Abbildung 9: Ficjan A, et al. IFI44L gene DNA methylation in iNKT cells from lupus patients and controls. DNA methylation fractions across the CG sites evaluated in the IFI44L gene.


Keywords: Diagramm,  DNA-Methylierung,  Lupus erythematodes,  Mineralstoffwechsel